Diet or medically treated gestational diabetes: is there any difference for obstetrical and neonatal complications? A French cohort study.

Objective: The aim of the present study was to determine specific obstetrical and neonatal complications associated with diet-treated gestational diabetes (DTGD) and medically treated gestational diabetes (MTGD).

Methods: This is a prospective cohort study of women followed in the Robert Debré Hospital (France, Paris) and who have given birth between 1 January, 2004, and 19 November, 2010. Clinical, biological, maternal and neonatal data were reported in the maternity database.

[Dealing with a "different" child in the delivery room].

Maternity ward staff face complex situations, handling not only births, but sometimes also deaths. When a serious condition is revealed during the prenatal diagnosis, an abortion may be requested, but other parents choose to keep their disabled child. In such cases, healthcare professionals must support parents in learning about this "different" child.

Excretion of ketoprofen and nalbuphine in human milk during treatment of maternal pain after delivery.

Analgesics are required to prevent and treat postpartum pain, but breast-feeding may be contraindicated, because data on milk transfer are very limited. The present study was undertaken to quantify the transfer of ketoprofen and nalbuphine in milk. Eighteen patients gave their informed consent to participate and completed the study.

Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.

Background: Fetuses from mothers with Graves' disease may experience hypothyroidism or hyperthyroidism due to transplacental transfer of antithyroid drugs (ATD) or anti-TSH receptor antibodies, respectively. Little is known about the fetal consequences. Early diagnosis is essential to successful management.